AVITA Medical, Inc. (AVH.AX)
AUD 2.9
(2.84%)
AUD 2.9
(2.84%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2022 | 34.42 Million USD | -24.27% |
| 2021 | 45.45 Million USD | 55.49% |
| 2020 | 29.23 Million USD | 104.95% |
| 2019 | 14.26 Million USD | 164.31% |
| 2018 | 5.39 Million AUD | 344.64% |
| 2017 | 1.21 Million AUD | 33.77% |
| 2016 | 907.25 Thousand AUD | 21.25% |
| 2015 | 748.28 Thousand AUD | -64.53% |
| 2014 | 2.1 Million AUD | -16.5% |
| 2013 | 2.52 Million AUD | -1.67% |
| 2012 | 2.56 Million AUD | -25.12% |
| 2011 | 3.43 Million AUD | 2.85% |
| 2010 | 3.33 Million AUD | 45.24% |
| 2009 | 2.29 Million AUD | -2.97% |
| 2008 | 2.36 Million AUD | 96.64% |
| 2007 | 1.2 Million AUD | 52.17% |
| 2006 | 790.99 Thousand AUD | -10.46% |
| 2005 | 883.38 Thousand AUD | 0.0% |
| 2003 | 389.07 Thousand AUD | 100.23% |
| 2002 | 194.31 Thousand AUD | 0.0% |
| 2001 | - AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | -100.0% |
| 1998 | 582.96 Thousand AUD | 0.0% |
| 1997 | - AUD | 0.0% |
| 1996 | - AUD | 0.0% |
| 1995 | - AUD | 0.0% |
| 1994 | - AUD | 0.0% |
| 1993 | - AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q2 | 11.75 Million USD | 11.4% |
| 2023 Q3 | 13.64 Million USD | 16.1% |
| 2023 Q1 | 10.55 Million USD | 11.58% |
| 2022 Q2 | 8.33 Million USD | 10.56% |
| 2022 Q4 | 9.45 Million USD | 3.99% |
| 2022 Q3 | 9.09 Million USD | 9.08% |
| 2022 Q1 | 7.53 Million USD | 8.69% |
| 2022 FY | 34.42 Million USD | -24.27% |
| 2021 FY | 45.45 Million USD | 55.49% |
| 2021 Q1 | 8.76 Million USD | 71.76% |
| 2021 Q2 | 10.3 Million USD | 17.56% |
| 2021 Q3 | 7.02 Million USD | -31.87% |
| 2021 Q4 | 6.93 Million USD | -1.2% |
| 2020 Q2 | 3.87 Million USD | 0.0% |
| 2020 FY | 29.23 Million USD | 104.95% |
| 2020 Q1 | 3.87 Million USD | 18.96% |
| 2020 Q3 | 5.06 Million USD | 30.51% |
| 2020 Q4 | 5.1 Million USD | 0.85% |
| 2019 Q1 | 2.94 Million USD | 225.21% |
| 2019 Q2 | 2.98 Million USD | 1.14% |
| 2019 Q4 | 3.25 Million USD | 0.28% |
| 2019 Q3 | 3.25 Million USD | 8.99% |
| 2019 FY | 14.26 Million USD | 164.31% |
| 2018 Q4 | 906.59 Thousand USD | -0.0% |
| 2018 FY | 5.39 Million AUD | 344.64% |
| 2018 Q3 | 906.59 Thousand USD | 157.22% |
| 2018 Q2 | 352.46 Thousand USD | 19.26% |
| 2018 Q1 | 295.55 Thousand USD | -2.74% |
| 2017 Q1 | 329.44 Thousand USD | 26.29% |
| 2017 Q4 | 303.88 Thousand USD | -0.0% |
| 2017 FY | 1.21 Million AUD | 33.77% |
| 2017 Q3 | 303.88 Thousand USD | -7.76% |
| 2017 Q2 | 329.44 Thousand USD | 0.0% |
| 2016 Q4 | 260.87 Thousand USD | 0.0% |
| 2016 FY | 907.25 Thousand AUD | 21.25% |
| 2016 Q2 | 214.73 Thousand USD | 0.0% |
| 2016 Q3 | 260.87 Thousand USD | 21.49% |
| 2016 Q1 | 214.73 Thousand USD | -24.99% |
| 2015 Q1 | 247.87 Thousand USD | 1.19% |
| 2015 Q2 | 247.87 Thousand USD | 0.0% |
| 2015 Q4 | 286.27 Thousand USD | 0.0% |
| 2015 Q3 | 286.27 Thousand USD | 15.49% |
| 2015 FY | 748.28 Thousand AUD | -64.53% |
| 2014 Q2 | 656.52 Thousand USD | 0.0% |
| 2014 FY | 2.1 Million AUD | -16.5% |
| 2014 Q4 | 244.95 Thousand USD | -0.0% |
| 2014 Q3 | 244.95 Thousand USD | -62.69% |
| 2014 Q1 | 656.52 Thousand USD | -4.16% |
| 2013 Q1 | 731.26 Thousand USD | 8.14% |
| 2013 FY | 2.52 Million AUD | -1.67% |
| 2013 Q4 | 685.03 Thousand USD | 0.0% |
| 2013 Q3 | 685.03 Thousand USD | -6.32% |
| 2013 Q2 | 731.26 Thousand USD | 0.0% |
| 2012 Q3 | 676.23 Thousand USD | -17.27% |
| 2012 Q1 | 817.35 Thousand USD | 0.0% |
| 2012 Q4 | 676.23 Thousand USD | 0.0% |
| 2012 Q2 | 817.35 Thousand USD | 0.0% |
| 2012 FY | 2.56 Million AUD | -25.12% |
| 2011 FY | 3.43 Million AUD | 2.85% |
| 2010 FY | 3.33 Million AUD | 45.24% |
| 2009 FY | 2.29 Million AUD | -2.97% |
| 2008 FY | 2.36 Million AUD | 96.64% |
| 2007 FY | 1.2 Million AUD | 52.17% |
| 2006 FY | 790.99 Thousand AUD | -10.46% |
| 2005 FY | 883.38 Thousand AUD | 0.0% |
| 2003 FY | 389.07 Thousand AUD | 100.23% |
| 2002 FY | 194.31 Thousand AUD | 0.0% |
| 2001 FY | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 1999 FY | - AUD | -100.0% |
| 1998 FY | 582.96 Thousand AUD | 0.0% |
| 1997 FY | - AUD | 0.0% |
| 1996 FY | - AUD | 0.0% |
| 1995 FY | - AUD | 0.0% |
| 1994 FY | - AUD | 0.0% |
| 1993 FY | - AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| 4DMedical Limited | 3.75 Million AUD | -816.853% |
| Adherium Limited | 840.98 Thousand AUD | -3992.953% |
| Aroa Biosurgery Limited | 63.35 Million AUD | 45.672% |
| Atomo Diagnostics Limited | 4.08 Million AUD | -742.303% |
| Anteris Technologies Ltd | 4.11 Million AUD | -737.274% |
| Control Bionics Limited | 5.12 Million AUD | -571.381% |
| CardieX Limited | 10.9 Million AUD | -215.626% |
| Compumedics Limited | 49.71 Million AUD | 30.769% |
| Cochlear Limited | 2.25 Billion AUD | 98.476% |
| CleanSpace Holdings Limited | 15.72 Million AUD | -118.939% |
| Cyclopharm Limited | 27.13 Million AUD | -26.83% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | -206.804% |
| Nova Eye Medical Limited | 23.32 Million AUD | -47.571% |
| HeraMED Limited | 402.89 Thousand AUD | -8443.375% |
| Imricor Medical Systems, Inc. | 615.56 Thousand AUD | -5491.746% |
| ImpediMed Limited | 10.31 Million AUD | -233.569% |
| InhaleRx Limited | 1.2 Million AUD | -2758.778% |
| LBT Innovations Limited | 1.25 Million AUD | -2640.525% |
| Micro-X Limited | 15.22 Million AUD | -126.127% |
| Neurotech International Limited | 1963.00 AUD | -1753389.557% |
| OncoSil Medical Limited | 1.56 Million AUD | -2098.887% |
| PolyNovo Limited | 103.19 Million AUD | 66.644% |
| Respiri Limited | 456.91 Thousand AUD | -7433.365% |
| SomnoMed Limited | 91.65 Million AUD | 62.443% |
| Universal Biosensors, Inc. | 6.63 Million AUD | -418.948% |
| Uscom Limited | 3.72 Million AUD | -823.596% |
| Visioneering Technologies, Inc. | 8.67 Million AUD | -297.013% |